Modulation of phosphatase of regenerating liver-1 within placental mesenchymal stem cells instigates the transition between epithelial-to-mesenchymal transition and mesenchymal-to-epithelial transition subsequent to hepatic fibrosis
Clinical and Molecular Hepatology · 2025
DOI: 10.3350/cmh.2024.0741 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Molecular Hepatology, 2025. Verfasst von Jae Yeon Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Science, CHA University, Seongnam, Korea. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Mesenchymal Stem Cells, Placenta, Liver Cirrhosis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT, Korean Fund for Regenerative Medicine.
Abstract (Originalsprache)
Background/Aims: Epithelial-to-mesenchymal transition (EMT) plays a crucial role in hepatic fibrogenesis and liver repair in chronic liver disease. Our research highlights the antifibrotic potential of placenta-derived mesenchymal stem cells (PD-MSCs) and the role of phosphatase of regenerating liver-1 (PRL-1) in promoting liver regeneration.
Methods
We evaluated the efficacy of PD-MSCs overexpressing PRL-1 (PD-MSCsPRL-1) in a bile duct ligationinduced rat injury model, focusing on their ability to regulate EMT.
Results
PD-MSCsPRL-1 significantly reduced mesenchymal markers by downregulating TGFB1/SMAD2, outperforming naïve PD-MSCs. The transplantation of PD-MSCsPRL-1 enhanced BMP7/SMAD1/5 expression, promoting epithelial marker expression and stimulating BMP7 within hepatocytes, modulating downstream SMAD signaling. Importantly, further validation confirmed that PRL-1 directly interacts with BMP7 in hepatocytes.
Conclusions
PRL-1 expression in PD-MSCsPRL-1 restores TGFB1/BMP7 balance, promoting hepatic regeneration through mesenchymal-to-epithelial transition. These findings highlight the therapeutic potential of engineered MSCs for liver disease and suggest innovative strategies for future stem cell therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Science, CHA University, Seongnam, Korea.
- Research Institute of Placental Science, CHA University, Seongnam, Korea.
- Department of Integrated Biomedical and Life Sciences, College of Health Science, Korea University, Seoul, Korea.
- Department of Clinical Laboratory Science, College of Health Sciences, Catholic University of Pusan, Busan, Korea.
- Department of Internal Medicine, Catholic University Medical College, Seoul, Korea.
- Advanced PLAB, PLABiologics Co., Ltd., Seongnam, Korea.
Förderung
- National Research Foundation of Korea
- Ministry of Science and ICT
- Korean Fund for Regenerative Medicine
Zitieren
APA
Kim, J. Y., Park, H., Park, S. Y., Kim, S. H., Lim, J. Y., Lee, K. S., Bae, S. H., & Kim, G. J. (2025). Modulation of phosphatase of regenerating liver-1 within placental mesenchymal stem cells instigates the transition between epithelial-to-mesenchymal transition and mesenchymal-to-epithelial transition subsequent to hepatic fibrosis. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2024.0741
Vancouver
Kim JY, Park H, Park SY, Kim SH, Lim JY, Lee KS, et al. Modulation of phosphatase of regenerating liver-1 within placental mesenchymal stem cells instigates the transition between epithelial-to-mesenchymal transition and mesenchymal-to-epithelial transition subsequent to hepatic fibrosis. Clinical and Molecular Hepatology. 2025. doi:10.3350/cmh.2024.0741
BibTeX
@article{Kim2025,
author = {Kim, Jae Yeon and Park, Hyeri and Park, Soo Young and Kim, Se Ho and Lim, Ja Yun and Lee, Ki Seog and Bae, Si Hyun and Kim, Gi Jin},
title = {Modulation of phosphatase of regenerating liver-1 within placental mesenchymal stem cells instigates the transition between epithelial-to-mesenchymal transition and mesenchymal-to-epithelial transition subsequent to hepatic fibrosis},
journal = {Clinical and Molecular Hepatology},
year = {2025},
doi = {10.3350/cmh.2024.0741}
}
EUVIMED